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Matrix tabletAbstract Chitosan derivative was successively synthesized by initial preparation of acyl thiourea
reagent using ammonium thiocyanate and making it to react with at primary amino groups of chito-
san and then reduced to yield Thiolated Chitosan. Due to the formation of disulphide bonds with
mFucus glycoproteins, mucoadhesiveness is augmented. The thiol groups were then quantiﬁed
using Ellman’s reagent. The derivatives inherit good swelling property in neutral and alkaline
media. The different derivatives containing thiol groups were formulated into tablets using refer-
ence drug for evaluation. The Thiolated Chitosan display in situ gelling features due to the pH-
dependent (alkaline pH) formation of inter-molecular disulphide bonds which makes the applica-
tion of Thiolated Chitosan on intestinal mucosa and can guarantee prolonged controlled release
of embedded therapeutic ingredients.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chitosan is a well-known polymer of study because of its bio-
compatibility, biodegradability and drug-absorption enhance-
ment. Chitosan is a multifunctional polymer but it is foundto devoid of pharmaceutical use because of poor or no water
solubility and alkaline solubility was far impossible.
Chitosan is obtained by deacetylation of chitin resulting the
free amino group that can make it be policationic (Champagne,
2008). Chitosan has proven to have mucoadhesive properties
due to electrostatic interactions between positively charged
chitosan and negatively charged mucosal surface. Thus, in a
context, Chitosan has one primary amino group and two free
hydroxyl groups for each monomer. Free amino group in chito-
san is positively charged subsequently react with the mucus are
negatively charged (Irene and Christine, 2007).
Various modiﬁcations have been made to the existing muco-
adhesive polymer resulting in a better mucoadhesive properties.
One modiﬁcation is done is with the immobilization of thiol
groups to mucoadhesive polymer so as to form disulphideArabian
2 S.B. Sonone et al.bonds with cysteine-rich subdomains of mucus glycoproteins.
Unlike the ﬁrst generation mucoadhesive polymers attached
to the mucus gel layer through non-covalent bonding, the
new generation of mucoadhesive polymers capable of forming
covalent bonds to the layer of mucus (Bowman and Leong,
2006).
The literature states that acylation of chitosan at amino
position results in increase in its water solubility 3. Further,
some chitosan conjugates with thiol containing moieties have
shown promising swelling property in alkaline pH (Irene and
Christine, 2007; Sreenivas and Pai, 2008). This article deals
with synthesis of some novel derivatives of chitosan possessing
thiol functional group obtained in stepwise reaction. The
derivatives were prepared by applying a simple thiouride syn-
thetic pathway which is then further reduced to form a Thio-
lated Chitosan derivative. The derivative shows a good
mucoadhesion, water solubility, swelling in alkaline pH which
can be used for controlled release for intestinal release. The
properties of the derivatives were assessed with various physio-
chemical tests as Swelling Index, Mucoadhesive strength, thiol
content, structural elucidation with NMR, etc. The derivatives
retain the acid solubility inherited from the precursor and
show enhanced new properties which further increases it usage
ability in pharmaceuticals. The derivatives thus have good
pharmaceutical and biological properties to be used as a poly-
mer in intestinal delivery of drug.R: -C6H5, -C6H4Cl, -C6,H4NH2, C3H4 
Figure 1 N-acyl Thiolated Chitosan derivatives.
Table 1 Quantiﬁcation of thiol group by Elman’s reagent.
Sr. no. Sample* Absorbance
(412 nm)
Sulphhydryl
content (moles)
1 TC1 0.3333 0.6608 · 10–7
2 TC2 0.2341 0.462 · 10–7
3 TC3 0.1611 0.3192 · 10–7
4 TC4 0.1898 0.3752 · 10–7
5 TC5 0.3113 0.6160 · 10–7
* TC1: N-benzoyl Thiolated Chitosan derivative, TC2:
N-(3-oxybenzoyl) Thiolated Chitosan derivative, TC3: N-(2-chloro-
4-oxybenzoyl) Thiolated Chitosan derivative, TC4: N-(4-amin-
obenzoyl) Thiolated Chitosan derivative TC5: N-Itaconoyl
Thiolated Chitosan derivative.2. Materials and methods
2.1. Materials
Chitosan (medium molecular mass: 400 KDa; degree of
deacetylation: 83–85%) was purchased from Research Labora-
tories, Acylchlorides, ammonium thiocyanate, Elman’s
Reagent were obtained from Research Lab and aluminium iso-
propoxide was procured from SIGMA. All chemicals were of
analytical grade. NMR analysis was performed at IIT (Powai).
2.2. Preparation of acylthiocyanate reagent
The solution of ammonium thiocyanate (0.011 mol) in dry ace-
tone (25 ml) was prepared. Benzoyl chloride (0.01 mol) was
added slowly in above solution with stirring. The reaction mix-
ture was subjected tomicrowave irradiation for 3 mins at 560 W
power to yield an acylthiocyanate reagent (Kumaraswamy
et al., 2006).
2.3. Synthesis of acylthiouride of chitosan
A solution of chitosan in 2%AcOH/MeOH (50 ml) was added
slowly to the above solution so as to maintain reﬂux condition.
After the addition was complete, the mixture was stirred for
90 min at room temperature, which is separated as solid pre-
cipitate on pouring in NaOH solution (pH 10) Zhong et al.,
2008; Champagne, 2008.
2.4. Synthesis of Thiolated Chitosan derivative
The above precipitate was washed with acetone thoroughly to
remove the traces of acylthiocyanate. The product was thenPlease cite this article in press as: Sonone, S.B. et al., Controlled release matrix table
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reduces the thioketone group from acylthiouride to form the
thiol resulting in the formation of Thiolated Chitosan. The
aluminium isopropoxide in isopropanol solution is as speciﬁc
reducing agent for ketones (Finar, 2006) (Fig. 1).
2.5. Procedure for quantiﬁcation of sulfhydryl groups
A dilution buffer (0.1 M Sodium phosphate, 1 mM EDTA, pH
8.0) and DTNB [(5,50-dithio-bis-(2-nitrobenzoic acid)] working
solution were prepared initially. The solutions were stored at
+4 C. 4 mg of DTNB was dissolved in 1 ml dilution buffer.
A set of Sulfhydryl standard (Cysteine HCl) with sample dilu-
tion buffer (or distilled water) was prepared. Cysteine HCl
(26.34 mg) was dissolve in the media to prepare 1.5 mM solu-
tion, serial dilutions 1.25 mM, 1.0 mM, 0.75 mM, 0.5 mM and
0.25 mM were prepared and were used immediately. Following
components were added subsequently to the test tubes:
250 ll Sample/Standard
2.5 ml dilution buffer
50 ll DTNB reagent
The resulting solution was incubated for 15 min and absor-
bance was measured at the wavelength of 412 nm and concen-
tration of Sulfhydryl group was determined using Cysteine as
standard solution. Molar extinction coefﬁcient at 412 nm oft formulation using synthesized N-acyl Thiolated Chitosan derivatives. Arabian
Controlled release matrix tablet formulation 3DTNB is 14,150 M1 cm1 (Irene and Christine, 2007; Alvear
et al., 1989) (Table 1).
2.6. Swelling Index
Swelling index of the synthesized derivative was determined by
soaking 150 mg ﬂat faced 8 mm tablet in 6 ml of water in a
Petri-dish. Initial and ﬁnal weights of the tablets were recorded
(Table 2).
Swelling index was calculated by using following formula:
Swelling index ¼ Final weight initial weight=Final weight
 1002.7. Solubility test
The solubility of the copolymers was tested in several organic
solvents, distilled water as well as in 0.1 M phosphate buffer
(pH 4.0), 0.1 M phosphate buffer (pH 7.0) and DMSO. TheTable 2 Swelling index of N-acyl Thiolated Chitosan
derivatives.
Sr. no. Sample Initial
weight (W1)
Final
weight (W2)
Swelling
index (%)
1 TC1 0.1508 0.5112 70.5
2 TC2 0.1651 0.7889 79.07
3 TC3 0.1559 0.718 78.28
4 TC4 0.1444 0.8132 82.24
5 TC5 0.1499 0.8411 82.18
Table 3 Solubility assessment of Thiolated Chitosans.
SAMPLE AQ.ACETIC ACID (2%) PBS+ (pH 4.8)
Chitosan ++++ ++
TC1 ++++ ++++
TC2 ++++ ++++
TC3 ++++ ++++
TC4 ++++ +++++
TC5 ++++ ++++
+Phosphate buffer solution. ++Dimethylsulphoxide.
Table 4 % Release (average with% dissolution efﬁciency and mean
Sr. no. Time Hr Avg. %R SD SEa-m
1 0 0.000 0.00 0.00
2 1 1.936 2.09 1.05
3 2 4.935 3.61 1.80
4 3 24.282 19.64 9.82
5 4 28.294 18.44 9.22
6 5 41.324 15.77 7.88
7 6 41.689 9.62 4.81
a Standard error.
b Dissolution efﬁciency.
c Mean dissolution time.
d Relative standard deviation.
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5 mg/ml (Gorochovceva and Kulbokaite, 2004) (Table 3).
2.8. Mucoadhesivity assessment
Recently, it has been shown that polymers with thiol groups
provide much higher adhesive properties than polymers gener-
ally considered to be mucoadhesive. The enhancement of
mucoadhesion can be explained by the formation of covalent
bonds between the polymer and the mucus layer which are
stronger than non-covalent bonds. This theory was supported
by the results of assessment of Mucoadhesive strength demon-
strated a positive correlation between the degree of modiﬁca-
tion with thiol bearing moieties and the adhesive properties
of the polymer (Sreenivas and Pai, 2008; Deshmane et al.,
2009).
For the measurement of the Mucoadhesive strength, the
pure polymer was taken and the disc of 150 mg was prepared
by using 8 mm die on the rotary compression machine. After
that the tablet was removed and used for the measurement
of the mucoadhesive strength (Fig. 4).
2.9. Thiol derivative as controlled release matrix
Thiolated Chitosan represents, primarily due to its mucoadhe-
sive properties, a valuable tool for non-invasive drug delivery.
The longer residence time of formulations based on mucoadhe-
sive polymers at the absorption site is believed to contribute to
an increased absorption rate of the incorporated drug. How-
ever, such an enhanced bioavailability can be achieved only
if a controlled release of the active agent out of the formulation
is provided. Thiolated Chitosans also display, besides theirWATER PBS (pH 7.4) DMSO++
– – –
++++ ++ (SWELLS) ++ (SWELLS)
++++ ++++ (SWELLS) +++ (SWELLS)
++++ ++ (SWELLS) ++ (SWELLS)
++++ ++++ (SWELLS) +++ (SWELLS)
++++ ++++ (SWELLS) +++ (SWELLS)
dissolution time).
ean Amt. (mg) % DEb MDTc RSDd
0.00 0.00 0.00 0.00
1.16 0.97 0.50 108.03
2.96 2.20 1.11 73.09
14.57 6.34 2.22 80.87
16.98 11.33 2.40 65.18
24.79 16.02 3.06 38.16
25.01 20.27 3.08 23.08
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excellent cohesive properties. The cohesion and stability of a
drug delivery system over the intended duration of drug liber-
ation is often a substantial requirement for a controlled
release. The usefulness of Thiolated Chitosans as carrier matri-
ces for controlled drug release was demonstrated with model
drug as Amodiaquine (Sreenivas and Pai, 2008) (Table 4).
3. Results and discussion
Five thiolated derivatives were synthesized viz; N-Benzoyl
thiolurea derivative, N-(3-oxybenzoyl) thiolurea derivative,I: N-benzoyl Thiolated Chitosan derivative; II: N-(4-aminobenzoyl) Thiolated Chitosan 
derivative; III: N-(3-oxybenzoyl) Thiolated Chitosan derivative; IV: N-itaconoyl Thiolated 
Chitosan derivative; V: N-(2-chloro-4-oxybenzoyl) Thiolated Chitosan derivative 
Figure 2 Ovelaid IR spectra for N-acyl Thiolated Chitosan
derivatives.
Figure 3 Ovelaid NMR spectra for N-
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benzoyl) thiolurea derivative and N-Itaconoyl thiolurea deri-
vative. The IR spectra (Fig. 2) and NMR spectra (Fig. 3)
were assessed for structural conﬁrmation.
Signiﬁcant IR peaks:
3435.56, O–H Stretch (H-bonded alcohols); 2064.42, C–O
stretch overtone (aryl–alkyl ether); 1383.68, S–H stretch
(aliphatic); 658.571, C–S Stretch.acyl Thiolated Chitosan derivatives.
Figure 4 Mucoadhesive strength for N-acyl Thiolated Chitosan
derivatives.
t formulation using synthesized N-acyl Thiolated Chitosan derivatives. Arabian
%R1: N-benzoylthiolurea derivative; %R2: N-(3-oxybenzoyl)thiolurea derivative; %R3: N-2-chloro-4-
oxybenzoyl)thiolurea derivative; %R4: N-(4-aminobenzoyl)thiolurea derivative; %R5: N-Itaconoylthiolurea 
derivative 
%
 D
ru
g 
Re
le
as
e
Time in Hrs
Figure 5 Release pattern of N-acyl Thiolated Chitosan deriva-
tives for a model drug (Amodiaquine).
Controlled release matrix tablet formulation 5Signiﬁcant NMR peaks:
5.067, tetrahydropyran methane; 4.414, 2 amine, 1 thiol of
N–C(SH)–N;4.161, tetrahydropyran methine C–O–, –N–
C‚O, –O from methane; 1.58, Thiol.
The thiolated derivatives of chitosan possess a distinctive
smell with characteristic pale yellowish colour and ﬁbrous
appearance. The derivatives are soluble in acid solution and
if added to water or alkaline media it disperses to form a high
viscosity gel like dispersion. Due to bulkier aromatic group it
provided hindrance to the thiol group to immobilize on pri-
mary amino group of chitosan. The resultant thiolated poly-
mer derivatives have shown good swelling property and
enhanced mucoadhesive strength due to the intermolecular dis-
ulphide linkage between the polymer and mucosa (Sreenivas
and Pai, 2008; Deshmane et al., 2009) (Fig. 4). The mucoadhe-
sive test was assessed by measuring the contact time of chito-
san derivatives and a sample intestinal mucosa. Because of
its mucoadhesive properties the resultant thiolated polymer
derivatives have shown prolong residence time of the dosage
form in the small intestine, the permeation enhancing effect,
Sustained drug release and good oral bioavailability of various
poorly absorbed drugs were improved.
Also the derivatives have shown a promising sustained
release property (Figure 5). The swelling behaviours of thePlease cite this article in press as: Sonone, S.B. et al., Controlled release matrix table
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.036polymer were assessed using a simple analysing method of
petri plate by checking the amount of water absorbed by the
tablet during the resident time (Deshmane et al., 2009)
(Table 2).
The proposed release pattern of the polymer was assessed
by transforming the polymer in tablet formulation and incor-
porating a model drug into it. The tablet was made to reside
in a dissolution test media and a timely sampled solution from
the dissolution jars revealed a controlled release of drug over a
speciﬁed period of time (Sreenivas and Pai, 2008).
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